A detailed history of Freestone Grove Partners LP transactions in Pfizer Inc stock. As of the latest transaction made, Freestone Grove Partners LP holds 31,287 shares of PFE stock, worth $760,274. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,287
Previous 18,134 72.53%
Holding current value
$760,274
Previous $481 Million 64.79%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$25.01 - $27.13 $328,956 - $356,840
13,153 Added 72.53%
31,287 $793 Million
Q4 2024

Feb 14, 2025

BUY
$24.8 - $30.19 $449,723 - $547,465
18,134 New
18,134 $481 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $136B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Freestone Grove Partners LP Portfolio

Follow Freestone Grove Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Grove Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Grove Partners LP with notifications on news.